Veröffentlichungen
Originalarbeiten, Bücher, Buchkapitel und Übersichtsartikel von Prof. Marcus Maurer
Verwendung: Beginnen Sie mit einer Übersicht über alle Publikationen. Verwenden Sie Tag-Links, um markierte Dokumente aufzulisten oder eine ganze Kategorie aufzulisten, z.B. Original Work (Originalarbeiten), Books (Bücher), Book Chapters (Buchkapitel), Reviews (Übersichtsartikel). Wenn Sie wissen, was Sie suchen, dann geben Sie diesen Begriff in das Suchfeld ein.
- [o.074] Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands (0)
- [o.003] Murine skin as a target for melatonin bioregulation (3)
- [o.034] Neurotrophin-3 regulates mast cell functions in neonatal mouse skin (0)
- [o.059] Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells (0)
- [o.597] Non-skin-related symptoms are common in chronic spontaneous urticaria and linked to active and uncontrolled disease: results from CURE (0)
- [o.446] Novel insights on MRGPRX2-mediated hypersensitivity to neuromuscular blocking agents and fluoroquinolones (0)
- [o.335] Olaparib Desensitization in a Patient with Recurrent Peritoneal Cancer (0)
- [o.103] Omalizumab – an effective and safe treatment of therapyresistant chronic spontaneous urticaria (2)
- [o.152] Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria (2)
- [o.152b] Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal (0)
- [o.242] Omalizumab for the treatment of chronic spontaneous urticaria: a meta-analysis of randomized clinical trials (1)
- [o.423] Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study (0)
- [o.421] Omalizumab in chronic inducible urticaria: a real-life study of efficacy, safety, predictors of treatment outcome and time to response (2)
- [o.163] Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy (0)
- [o.180] Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis (2)
- [o.283] Omalizumab is effective in cold urticaria – results of a randomized, placebo controlled trial (6)
- [o.427] Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria (2)
- [o.282] Omalizumab is effective in symptomatic dermographism – results of a randomized, placebo controlled trial (6)
- [o.228] Omalizumab may not inhibit mast cell and basophil activation in vitro (2)
- [o.339] Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double‐blind, placebo‐controlled study (2)
(Last update: 06.2024)
| Number of original publications in peer-reviewed journals: | 612 |
| Number of reviews in peer-reviewed journals: | 217 |
| Number of publications (original work and reviews) in peer-reviewed journals: | 829 |
| Cumulative IF for original publications in peer-reviewed journals: | 4364.99 |
| Cumulative IF for reviews in peer-reviewed journals: | 1567.62 |
| Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5932.61 |
| Total number of citations: 37,066, h-index: 98 (Web of Science Juni 2024) | 37066 |
Download-Information
Um die angebotenen Veröffentlichungen herunterladen zu können, müssen Sie sich einloggen. Wenn Sie das Login nicht kennen, schreiben Sie mir bitte Ihre Anfrage.